stay up to date on this topic
one of the most frightening things a mid-life woman can hear these days is her increased risk for dementia as she approaches menopause.
women represent
two-thirds of the fast-rising alzheimer’s and dementia caseload globally. obviously everyone wants to know why and what we can do about it.
loss of estrogen, which has
long been demonstrated to have protective effects in the brain, is an obvious suspect, and a flurry of closely-watched research is underway trying to pin this down how this is all connected.
the most recent study to get everyone excited was
published in the journal
alzheimer’s research and therapy in january. broadly speaking, it found that introducing hormone therapy in women who had the apoe4 gene, which heightens risks for later development of alzheimer’s, led to improvements in memory and cognitive function, and larger brain volumes later in life.
it’s tempting to leap on hormone therapy when you are afraid of losing your mind
according to researchers at the university of east anglia’s norwich medical school, where the research was conducted, the findings demonstrate the “potential importance” of hrt in the face of our outsized risks.
“it’s too early to say for sure that hrt reduces dementia risk in women, but our results highlight the potential importance of hrt and personalized medicine in reducing alzheimer’s risk,”
uea’s norwich medical school’s professor michael hornberger told
the guardian.
it’s tempting to leap on hormone therapy when you are scared of losing your mind, as many women in the throes of perimenopause are. and no wonder: our brain power and cognitive function can drop significantly during this transition, according to brain scans.
lisa mosconi is an american neuroscientist and author of the 2020
new york times bestseller
the xx brain: the groundbreaking science empowering women to prevent dementia. she is also a
leading researcher looking at how these supposedly temporary changes are connected to our future cognition — or lack of it. one of her studies, published in
neurology in 2021, indicated middle-aged women were more likely than men to exhibit evidence of changes related to alzheimer’s disease, even when they show no outward differences in thinking and memory.